Identification of novel drugs to target dormant micrometastases

BACKGROUND: Cancer-specific survival has changed remarkably little over the past half century, mainly because metastases that are occult at diagnosis and generally resistant to chemotherapy subsequently develop months, years or even decades following definitive therapy. Targeting the dormant microme...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurst, Robert E., Hauser, Paul J., You, Youngjae, Bailey-Downs, Lora C., Bastian, Anja, Matthews, Stephen M., Thorpe, Jessica, Earle, Christine, Bourguignon, Lilly Y. W., Ihnat, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434572/
https://www.ncbi.nlm.nih.gov/pubmed/25971923
http://dx.doi.org/10.1186/s12885-015-1409-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434572/
https://www.ncbi.nlm.nih.gov/pubmed/25971923
http://dx.doi.org/10.1186/s12885-015-1409-4

Ejemplares similares